Between Coronary Angiography and Fractional Flow Reserve

Similar documents
New Insight about FFR and IVUS MLA

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

Integrated Use of IVUS and FFR for LM Stenting

Declaration of conflict of interest. Nothing to disclose

Plaque Shift vs. Carina Shift Prevalence and Implication

Upgrade of Recommendation

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

Basics of Angiographic Interpretation Analysis of Angiography

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Percutaneous Intervention of Unprotected Left Main Disease

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea

Can We Safely Defer PCI. Yes, already proven

Debate Should we use FFR? I will say NO.

Prognostic Value of Gated Myocardial Perfusion SPECT

PCI for Left Anterior Descending Artery Ostial Stenosis

FFR and intravascular imaging, which of which?

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

PCI for Long Coronary Lesion

PROMUS Element Experience In AMC

FFR-guided Jailed Side Branch Intervention

The MAIN-COMPARE Study

Diffuse Disease and Serial Stenoses

Unprotected LM intervention

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Diffuse Disease and Serial Stenoses. Bernard De Bruyne Cardiovascular Center Aalst Belgium

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Noninvasive Fractional Flow Reserve from Coronary CT Angiography

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

CASE from South Korea

Side Branch Occlusion

Clinical case in perspective. Cases from Poland

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

FFR CT : Beyond FFR. Bon-Kwon Koo, MD, PhD. Seoul National University Hospital, Seoul, Korea. Seoul National University Hospital Cardiovascular Center

Left Main Intervention: Will it become standard of care?

Fractional Flow Reserve. A physiological approach to guide complex interventions

Technical Aspects and Clinical Indications of FFR

Benefit of Performing PCI Based on FFR

Diagnostic Accuracy of Fractional Flow Reserve from Anatomic Computed TOmographic Angiography: The DeFACTO Study

Why I try to avoid side branch dilatation

LM stenting - Cypher

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Stent Fracture and Longitudinal Compression on CT Angiography between the

Fractional Flow Reserve (FFR) estimation GRAIDIS CHRISTOS. EUROMEDICA-KYΑNOUS STAVROS Interventional Cardiologist, FSCAI

Renal fractional flow reserve and hypertension response after renal artery stenting

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Anatomical, physiological and clinical relevance of a side branch

The MAIN-COMPARE Registry

IVUS vs FFR Debate: IVUS-Guided PCI

OCT guidance for distal LM lesions

Post PCI functional testing and imaging: case based lessons from FFR React

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

FFR in Left Main Disease

PCI vs. CABG From BARI to Syntax, Is The Game Over?

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

Control of Myocardial Blood Flow

Important LM bifurcation studies update

FFR in diffuse disease and serial stenoses

Fractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου

Fractional Flow Reserve (FFR)

FFR and IVUS Guided DES Implantation in Long Diffuse Lesions

The SYNTAX-LE MANS Study

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

Case Review: Borderline LM with IVUS and FFR. Ravi Ramana, DO Heart Care Centers of Illinois SCAI Annual Conference 2010

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Factors influencing the functional significance in intermediate coronary stenosis

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Functional Assessment of Jailed Side Branches in Coronary Bifurcation Lesions Using Fractional Flow Reserve

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

DECISION - CTO. optimal Medical Treatment in patients with. Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

Cafri C; Zahger D; Rosenshtein G, Kleshian I; Ilia R

Left Main Intervention: Where are we in 2015?

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

PCI for In-Stent Restenosis. CardioVascular Research Foundation

Radiation Safety Abbott Vascular. All rights reserved.

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

Bifurcation stenting with BVS

FRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!!

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN

Can IVUS Define Plaque Features that Impact Patient Care?

Abstract Background: Methods: Results: Conclusions:

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

Transcription:

Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea

Visual - Functional Mismatch Angiographic DS(%) : 85% IVUS MLA : 2.8 mm 2 FFR : 0.84 Treadmill test : Negative Thallium spect : Normal Stress Echo : Normal

Reverse Mismatch Visual Estimation : 30% FFR : 0.70 IVUS MLA: 4.5 mm2 Treadmill test: + stage 2 Thallium spect : + large LAD

How many Mismatches?

Mismatch Disease in the Cath Lab Comparison analysis; Angiography vs. FFR (n=3000) 1.0 0.9 0.8 Mismatch FFR FFR 0.7 06 0.6 0.5 0.4 Reverse 0.3 Mismatch 0.2 0.1 0.0 0 10 20 30 40 50 60 70 80 90 100 QCA Diameter Stenosis (%) QCA Courtesy of Bernard De Bruyne, MD, PhD,

Mismatches ; Significant Stenosis (>50%) with Negative FFR Reverse Mismatches ; Insignificant Stenosis (<50%) with Positive FFR

Background Lesion severity determined by coronary angiography has not been well-correlated with the physiologic significance of the stenosis However, the reasons why mismatches between the two, are still poorly understood.

Methods 1 Computational Simulation Numerical simulation was performed using a commercial computational fluid dynamics simulation code, ANSYS FLUENT release 13.0 A built-in porous media model in ANSYS FLUENT release 13.0 was used to simulate microvascular bed resistance change of myocardium due to change of coronary severity under hyperemic flow condition

Methods 2 Clinical Data in 1000 Patients Between November 2009 and June 2011, in a prospective cohort, 1000 consecutive patients with 1129 coronary lesions, underwent angiographic, IVUS, and FFR assessment prior to intervention (ClinicalTrials.gov numbers NCT01366404) All patients were aged 35-85 years and had one target vessel with >30% of QCA-DS on visual estimation

FFR theory FFR is determined by 1. Size of myocardium 2. Many lesion specific local factors at maximal hyperemia.

Methods 1 Studies Computational Simulation Study

Steady-state 3D Simulation under Hyperemic Condition 120mmHg 1115 100 85 70 Pressure contours Velocity vectors

Recirculation Why (Vortex) Can make Pressure a Energy Drop Loss? of Fluid Pressure Drop P1 P2

Steady-state 3D Simulation under Hyperemic Condition FFR 0.62 Recirculation

Pressure Drop due to Energy Loss of Fluid by Vortex Flow 1 : P1 + 1/2pv1 2 =Pt 1 2 : P2 + 1/2pv2 2 =Pt 2 3 : P3 + 1/2pv3 2 =Pt 3 Pt 1 > Pt 2 Pt 1 >> Pt Pt 3 4 Courtesy of Prof. Shim

Degree of Stenosis 30% 50% 70% FFR 0.91 0.80 0.58

Different Morphology 50% FFR 0.76 0.71 0.61

Different Lesion Length 10mm Degree of stenosis : 50% FFR 080 0.80 20mm 0.76 30mm 0.71

Lesion Eccentricity (cross-sectional) sectional) Eccentric Model FFR 0.71 Concentric Model CSA : 1.83 mm² 0.77 CSA :1.83mm²

FFR theory Vulnerable Plaque Simulation Plaque rupture Thrombus, surface roughness

Presence of Plaque Rupture 70% FFR : 0.62 70% 0.68 70% 0.66 70% 058 0.58

Different Surface Roughness 50% Smooth Surface Roughness 0.05 mm Roughness 0.1mm Roughness 0.2 mm 0mm 20 FFR : 0.81 0.72 0.60 0.54

Rupture and Roughness 70 % 0.636 70 %, Rupture 0.631 70 %, Rupture and Roughness 0.505

FFR is influenced by Many Lesion Specific Factors Degree of diameter stenosis Reference vessel diameter (myocardium) Lesion morphology Eccentricity Lesion length Plaque burden, Plaque rupture Surface roughness (thrombus) Viscous friction, flow separation, turbulence, and eddies

Conclusion 1 1. Although the same degree of stenosis can make a different FFR value according to the different lesion morphologic factors. 2. FFR, a very sensitive index integrating various local factors, is more reliable than angiographically g determined stenosis severity.

Methods 2 Clinical Data in 1000 Patients

Prospective Cohort, 1000 patients t (1129 lesions) 100% QCA analysis 100% FFR 100% IVUS assessment and core lab analysis (ClinicalTrials.gov i lt i l numbers NCT01366404)

Inclusion Criteria, All patients were aged 35-85 years and had one target vessel with >30% diameter stenosis on visual estimation.

Exclusion Criteria, i multiple stenoses within a single target vessel, bypass graft lesions, side branch lesions, in-stent restenosis, previous PCI in the target vessel, STEMI, TIMI flow <3, angiographic thrombi-containing lesions, IVUS-imaging catheter or FFR wire failed to cross the lesion

Clinical Characteristics (overall pt.) Age (years) 61±9 Male 731 (73%) Diabetes, N (%) 322 (32%) Hypertension, N (%) 589 (59%) Smoking, N (%) 493 (49%) Hyperlipidemia, N (%) 670 (67%) Previous PCI, N (%) 122 (12%) Left main coronary artery disease 63 (6%) Clinical manifestation Stable angina, N (%) 742 (74%) Unstable angina, N (%) 219 (22%) Non-ST elevation MI, N (%) 39 (4%)

Lesion Characteristics (overall lesions) Lesion location Syntax No 5 (LMCA) Syntax No 6 (proximal LAD) Syntax No 7 (mid LAD) Syntax No 8 (distal LAD) Syntax No 11 (proximal LCX) Syntax No 13 (distal LCX) Syntax No 1 (proximal RCA) Syntax No 2 (mid RCA) Syntax No 3 (distal RCA) N=1129 63 (6%) 236 (21%) 432 (38%) 36 (3%) 39 (3%) 60 (5%) 111 (10%) 114 (10%) 38 (3%) FFR in non-left main lesions 0.82±0.09 FFR in left main lesions 0.80±0.09 09 FFR <0.80 368 (32.6%)

Angiographic findings QCA and IVUS Data in 1066 Non-LM Lesions Proximal reference lumen diameter, mm 3.4±0.5 Distal reference lumen diameter, mm 2.8±0.5 Minimal lumen diameter, mm 15±0 1.5±0.4 Diameter stenosis, % 51.4±12.2 Lesion length (mm) 19.4±12.2 IVUS findings Proximal reference mean lumen area, mm 2 9.10±3.3 Proximal reference mean EEM area, mm 2 15.6±4.9 Distal reference mean lumen area, mm 2 7.3±2.9 Distal reference mean EEM area, mm 2 11.4±4.9 Minimal lumen area, mm 2 2.7±1.2 Plaque burden at the minimal lumen area site, ste,% 73.6±12.1 Plaque rupture 123 (11.5%)

Angiographic findings QCA and IVUS Data in 63 LM Lesions Proximal reference lumen diameter, mm 3.8±0.6 Distal reference lumen diameter, mm 3.4±0.5 Minimal lumen diameter, mm 1.9±0.5 Diameter stenosis, % 47.0±11.1 1 Lesion length (mm) 11.1±8.3 IVUS findings EEM at the minimal lumen area site, mm 2 18.0±5.4 Minimal lumen area, mm 2 5.0±2.1 Plaque burden at the minimal lumen area site, % 70.3±14.4 Plaque rupture 22 (34.9%)

How many Mismatches?

1066 Non-LM lesions 63 LM lesions 1.0 09 0.9 0.8 57% Mismatch 1.0 0.9 35% Mismatch FFR 0.7 0.6 0.5 04 0.4 0.3 0 16% Reverse mismatch 20 40 60 80 100 FR F 0.8 0.7 0.6 20 40% Reverse mismatch diameter stenosis (%) diameter stenosis (%) 30 40 50 60 70 80

Frequencies of Mismatch 100 90 80 70 60 50 40 30 20 10 0 LM non-lm LAD LCX RCA proximal mid distal rupture nonrupture DS 50% and FFR 0.80 DS>50% and FFR<0.80 Reverse-mismatch Mismatch

Cut-off of QCA-DS to Predict FFR <0.80 100 Non-LMCA 100 LMCA 80 80 Sen nsitivity 60 40 20 0 60 52% 40 46% DS >52% AUC 0.73 95%CI 0.70 0.75 0 20 40 60 80 100 100-Specificity ensitivity S 20 0 DS >46% AUC 0.66 95%CI 0.53 0.77 0 20 40 60 80 100 100-Specificity Sensitivity 66% Specificity 67% PPV 48% NPV 81% Accuracy 66% Sensitivity 61% Specificity 59% Accuracy 60%

Correlations of Variables with FFR Non-LM lesions LM lesions r p r p Angiographic DS -0.395 p<0.001-0.428 p<0.001 Angiographic MLD 0.414 p<0.001001 0.436 p<0.001001 Lesion length -0.235 p<0.001-0.216 0.089 Minimal lumen area 0.467 p<0.001 0.560 p<0.001 Plaque burden -0.350 p<0.001-0.473 p<0.001

- Univariate Analysis - Why Mismatches

Comparison of Clinical Data QCA-DS>50% QCA-DS 50% FFR<0.80 FFR 0.80 Mismatch FFR 0.80 FFR<0.80 Rev-mismatch N 262 343 386 75 Age (years) 59.7±10.0 0 62.1±10.0 0 # 62.9±9.2 2 59.7±10.0 0* Female, N (%) 55 (21%) 107 (31%) # 103 (27%) 13 (17%) Diabetes, N (%) 82 (31%) 111 (32%) 121 (31%) 17 (23%) Hypertension, N (%) 157 (60%) 201 (59%) 227 (59%) 43 (57%) Smoking, N (%) 142 (54%) 160 (47%) 195 (51%) 45 (60%) ACS, N (%) 72 (28%) 101 (29%) 115 (30%) 20 (27%) LAD, N (%) 201 (77%) 191 (56%) # 246 (64%) 66 (88%)* LCX, N (%) 14 (5%) 49 (14%) # 30 (8%) 6 (8%) RCA, N (%) 47 (18%) 103 (30%) # 110 (29%) 3 (4%)* # p value <0.05, vs. 262 lesions with QCA-DS>50 and FFR<0.80 * p value <0.05, vs. 386 lesions with QCA-DS 50% and FFR 0.80

Comparison of QCA and IVUS Findings QCA-DS>50% FFR<0.80 FFR 0.80 Mismatch FFR 0.80 QCA-DS 50% FFR<0.80 Rev-mismatch N 262 343 386 75 Proximal segment 91 (35%) 129 (38%) 139 (36%) 27 (36%) Distal segment 29 (11%) 58 (17%) # 42 (11%) 5 (7%) Lesions length, mm 24.1±13.4 18.8±10.6 # 16.7±11.2 19.3±12.3 QCA-DS, % 62.3±9.2 57.6±7.4 # 40.1±6.6 43.2±5.2* QCA-MLD, mm 1.2±0.3 1.4±0.3 # 1.9±0.3 1.7±0.3* Averaged RLD, mm 3.1±0.5 3.2±0.5 # 3.1±0.5 3.0±0.5* MLA, mm 2 1.9±0.7 2.6±0.9 # 3.4±1.3 2.4±0.8* Plaque burden, % 80.8±8.7 74.7±9.9 # 67.8±13.0 73.1±12.1* Plaque rupture 44 (17%) 35 (10%) # 32 (8%) 12 (16%)* # p value <0.05, vs. 262 lesions with QCA-DS>50 and FFR<0.80 * p value <0.05, vs. 386 lesions with QCA-DS 50% and FFR 0.80

Comparison of Clinical Data in LM QCA-DS>50% QCA-DS 50% FFR<0.80 FFR 0.80 FFR<0.80 FFR 0.80 Mismatch Rev-mismatch N 15 8 24 16 Age (years) 61.8±11.5 63.8±10.3 60.8±12.4 56.1±9.8 Age (years) 4 (27%) 2 (25%) 9 (38%) 2 (13%) Female, N (%) 5 (33%) 2 (25%) 98 (33%) 6 (38%) Diabetes, N (%) 11 (73%) 3 (38%) 12 (50%) 8 (50%) Hypertension, N (%) 8 (53%) 5 (62%) 9 (38%) 12 (75%)* ACS, N 8 (53%) 2 (25%) 13 (54%) 7 (44%) # p value <0.05, vs. 15 lesions with QCA-DS>50 and FFR<0.80 * p value <0.05, vs. 24 lesions with QCA-DS 50% and FFR 0.80

Comparison of QCA and IVUS in LM QCA-DS>50% QCA-DS 50% FFR<0.80 FFR 0.80 FFR<0.80 FFR 0.80 Mismatch Rev-mismatch N 15 8 24 16 Lesions length, mm 14.7±13.4 6.5±1.9 9.4±5.1 12.8±6.4 QCA-DS, % 60.0±7.8 55.9±8.4 40.0±6.8 41.3±5.7 QCA-MLD, mm 1.4±0.3 1.6±0.4 2.3±0.4 2.1±0.4 Averaged RLD, mm 3.5±0.5 3.7±0.6 3.6±0.5 3.5±0.5 MLA, mm 2 3.4±1.6 4.8±1.6 # 6.6±2.0 4.2±1.4* Plaque burden, % 81.0±8.4 69.5±18.3 61.2±14.3 73.1±9.6* EEM area, mm 2 18.3±3.8 19.4±8.7 18.8±5.8 16.1±3.5 Plaque rupture 10 (67%) 3 (38%) 4 (17%) 8 (50%)* # p value <0.05, vs. 15 lesions with QCA-DS>50 and FFR<0.80 * p value <0.05, vs. 24 lesions with QCA-DS 50% and FFR 0.80

- Multivariable Analysis - Why Mismatches

Independent Factors for Mismatch Beta SE p-value Adjusted OR 95% CI Age 0.040040 0.012012 <0.001001 1.040 1.017 1.064 Female 0.430 0.250 0.085 1.537 0.942 2.508 LAD location -1.094 0.227 <0.001 0.335 0.214 0.522 Plaque rupture -0.956 0.334 0.004 0.385 0.200 0.740 Lesion length -0.033 0.008 <0.001 0.966 0.950 0.982 IVUS-MLA 0.687 0.189 0.001 1.989 1.371 2.886 Plaque burden -0.050 0.014 <0.001 0.951 0.926 0.977 QCA-MLD 0.086 0.040 0.034 1.089 1.007 1.179 * assessed by GEE in 937 patients with 1066. non-lmca lesions included age, female gender, lesions length, LAD location, proximal segment, plaque rupture, RLD, MLA, plaque burden, and averaged RLD

Independent Factors Predicting Reverse-Mismatch Beta SE p-value Adjusted OR 95% CI Age -0.044 0.015 0.003 0.957 0.929 0.985 LAD location 1.691 0.457 <0.001001 5.427 2.216216 13.29 Plaque rupture 1.150 0.452 0.011 3.159 1.301 7.667 IVUS-MLA -1.064 0.203 <0.001 0.345 0.232 0.514 Plaque burden 0.032 0.014 0.027 1.032 1.003 1.061 * assessed by GEE in 937 patients with 1066. non-lmca lesions included age, female gender, lesions length, LAD location, proximal segment, plaque rupture, RLD, MLA, plaque burden, and averaged RLD

Independent Predictors Mismatch Older age Non-LAD location Shorter lesion length Larger MLA by IVUS Larger MLD by QCA Smaller PB -Multivariable Analysis- Reverse- Mismatch Younger age LAD location Plaque Rupture Smaller MLA by IVUS Larger PB

Conclusions The discrepancy between coronary angiography and FFR, was attributable to various clinical and lesionspecific factors frequently unrecognizable in diagnostic coronary angiography. Thus, FFR, a clinical ischemia index integrating g various local factors, is more reliable than angiographically g determined stenosis severity.